ArticleKeratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma
ArticleKeratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma
ArticleCytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression
ArticleCytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression
ArticlePrognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer
ArticlePrognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer
ArticleRole of HER2 and Claudins in Subtypes of Urothelial Carcinoma Identified Bygata3 and Cytokeratin5\6 Immunohistochemical Study
ArticleRole of HER2 and Claudins in Subtypes of Urothelial Carcinoma Identified Bygata3 and Cytokeratin5\6 Immunohistochemical Study
ArticleImmunohistochemical Study of the Role of CK20, p53 and Ki-67 in Differentiation of Some Urothelial Lesions and Urothelial Carcinoma of the Urinary Bladder
ArticleImmunohistochemical Study of the Role of CK20, p53 and Ki-67 in Differentiation of Some Urothelial Lesions and Urothelial Carcinoma of the Urinary Bladder
ArticleImmunohistochemical Expression of HER2/NEU and CD10 in Urothelial Carcinoma of Urinary Bladder
ArticleImmunohistochemical Expression of HER2/NEU and CD10 in Urothelial Carcinoma of Urinary Bladder
ArticleSignificance of D2-40 and CXCL5 Expression in Urinary Bladder Transitional Cell Carcinoma: An Immunohistochemical Study
ArticleSignificance of D2-40 and CXCL5 Expression in Urinary Bladder Transitional Cell Carcinoma: An Immunohistochemical Study